Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
TRAIL and its receptors as targets for cancer therapy Yagita H; Takeda K; Hayakawa Y; Smyth MJ; Okumura KCancer Sci 2004[Oct]; 95 (10): 777-83Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a member of the TNF family of cytokines, which can induce apoptotic cell death in a variety of tumor cells by engaging the death receptors DR4 and DR5, while sparing most normal cells. Preclinical studies in mice and non-human primates have shown the potential utility of recombinant soluble TRAIL and agonistic anti-DR5 or DR4 antibodies for cancer therapy. Moreover, we have recently revealed a vital role for endogenously expressed TRAIL in immunosurveillance of developing and metastatic tumors. In this review, we summarize recent knowledge about TRAIL and its receptors as promising targets for cancer therapy.|*Drug Delivery Systems[MESH]|Animals[MESH]|Antibodies, Monoclonal/therapeutic use[MESH]|Antineoplastic Agents/*pharmacology[MESH]|Apoptosis[MESH]|Apoptosis Regulatory Proteins[MESH]|Humans[MESH]|Immunologic Surveillance[MESH]|Membrane Glycoproteins/*drug effects[MESH]|Mice[MESH]|Models, Biological[MESH]|Receptors, TNF-Related Apoptosis-Inducing Ligand[MESH]|Receptors, Tumor Necrosis Factor/*drug effects/immunology[MESH]|Recombinant Proteins/pharmacology[MESH]|TNF-Related Apoptosis-Inducing Ligand[MESH]|Tumor Necrosis Factor-alpha/*drug effects[MESH] |
